1 Introduction to Research & Analysis Reports
    1.1 Nuclear Medicine/Radiopharmaceutic Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Nuclear Medicine/Radiopharmaceutic Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Nuclear Medicine/Radiopharmaceutic Overall Market Size
    2.1 Global Nuclear Medicine/Radiopharmaceutic Market Size: 2021 VS 2028
    2.2 Global Nuclear Medicine/Radiopharmaceutic Revenue, Prospects & Forecasts: 2017-2028
    2.3 Global Nuclear Medicine/Radiopharmaceutic Sales: 2017-2028
3 Company Landscape
    3.1 Top Nuclear Medicine/Radiopharmaceutic Players in Global Market
    3.2 Top Global Nuclear Medicine/Radiopharmaceutic Companies Ranked by Revenue
    3.3 Global Nuclear Medicine/Radiopharmaceutic Revenue by Companies
    3.4 Global Nuclear Medicine/Radiopharmaceutic Sales by Companies
    3.5 Global Nuclear Medicine/Radiopharmaceutic Price by Manufacturer (2017-2022)
    3.6 Top 3 and Top 5 Nuclear Medicine/Radiopharmaceutic Companies in Global Market, by Revenue in 2021
    3.7 Global Manufacturers Nuclear Medicine/Radiopharmaceutic Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Nuclear Medicine/Radiopharmaceutic Players in Global Market
        3.8.1 List of Global Tier 1 Nuclear Medicine/Radiopharmaceutic Companies
        3.8.2 List of Global Tier 2 and Tier 3 Nuclear Medicine/Radiopharmaceutic Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Nuclear Medicine/Radiopharmaceutic Market Size Markets, 2021 & 2028
        4.1.2 Tc-99
        4.1.3 I-123/131
        4.1.4 In-111
        4.1.5 Xe-133
        4.1.6 Th-201
        4.1.7 Ga-67
        4.1.8 Other
    4.2 By Type - Global Nuclear Medicine/Radiopharmaceutic Revenue & Forecasts
        4.2.1 By Type - Global Nuclear Medicine/Radiopharmaceutic Revenue, 2017-2022
        4.2.2 By Type - Global Nuclear Medicine/Radiopharmaceutic Revenue, 2023-2028
        4.2.3 By Type - Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share, 2017-2028
    4.3 By Type - Global Nuclear Medicine/Radiopharmaceutic Sales & Forecasts
        4.3.1 By Type - Global Nuclear Medicine/Radiopharmaceutic Sales, 2017-2022
        4.3.2 By Type - Global Nuclear Medicine/Radiopharmaceutic Sales, 2023-2028
        4.3.3 By Type - Global Nuclear Medicine/Radiopharmaceutic Sales Market Share, 2017-2028
    4.4 By Type - Global Nuclear Medicine/Radiopharmaceutic Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
    5.1 Overview
        5.1.1 By Application - Global Nuclear Medicine/Radiopharmaceutic Market Size, 2021 & 2028
        5.1.2 Diagnostic
        5.1.3 Therapeutic
    5.2 By Application - Global Nuclear Medicine/Radiopharmaceutic Revenue & Forecasts
        5.2.1 By Application - Global Nuclear Medicine/Radiopharmaceutic Revenue, 2017-2022
        5.2.2 By Application - Global Nuclear Medicine/Radiopharmaceutic Revenue, 2023-2028
        5.2.3 By Application - Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share, 2017-2028
    5.3 By Application - Global Nuclear Medicine/Radiopharmaceutic Sales & Forecasts
        5.3.1 By Application - Global Nuclear Medicine/Radiopharmaceutic Sales, 2017-2022
        5.3.2 By Application - Global Nuclear Medicine/Radiopharmaceutic Sales, 2023-2028
        5.3.3 By Application - Global Nuclear Medicine/Radiopharmaceutic Sales Market Share, 2017-2028
    5.4 By Application - Global Nuclear Medicine/Radiopharmaceutic Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
    6.1 By Region - Global Nuclear Medicine/Radiopharmaceutic Market Size, 2021 & 2028
    6.2 By Region - Global Nuclear Medicine/Radiopharmaceutic Revenue & Forecasts
        6.2.1 By Region - Global Nuclear Medicine/Radiopharmaceutic Revenue, 2017-2022
        6.2.2 By Region - Global Nuclear Medicine/Radiopharmaceutic Revenue, 2023-2028
        6.2.3 By Region - Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share, 2017-2028
    6.3 By Region - Global Nuclear Medicine/Radiopharmaceutic Sales & Forecasts
        6.3.1 By Region - Global Nuclear Medicine/Radiopharmaceutic Sales, 2017-2022
        6.3.2 By Region - Global Nuclear Medicine/Radiopharmaceutic Sales, 2023-2028
        6.3.3 By Region - Global Nuclear Medicine/Radiopharmaceutic Sales Market Share, 2017-2028
    6.4 North America
        6.4.1 By Country - North America Nuclear Medicine/Radiopharmaceutic Revenue, 2017-2028
        6.4.2 By Country - North America Nuclear Medicine/Radiopharmaceutic Sales, 2017-2028
        6.4.3 US Nuclear Medicine/Radiopharmaceutic Market Size, 2017-2028
        6.4.4 Canada Nuclear Medicine/Radiopharmaceutic Market Size, 2017-2028
        6.4.5 Mexico Nuclear Medicine/Radiopharmaceutic Market Size, 2017-2028
    6.5 Europe
        6.5.1 By Country - Europe Nuclear Medicine/Radiopharmaceutic Revenue, 2017-2028
        6.5.2 By Country - Europe Nuclear Medicine/Radiopharmaceutic Sales, 2017-2028
        6.5.3 Germany Nuclear Medicine/Radiopharmaceutic Market Size, 2017-2028
        6.5.4 France Nuclear Medicine/Radiopharmaceutic Market Size, 2017-2028
        6.5.5 U.K. Nuclear Medicine/Radiopharmaceutic Market Size, 2017-2028
        6.5.6 Italy Nuclear Medicine/Radiopharmaceutic Market Size, 2017-2028
        6.5.7 Russia Nuclear Medicine/Radiopharmaceutic Market Size, 2017-2028
        6.5.8 Nordic Countries Nuclear Medicine/Radiopharmaceutic Market Size, 2017-2028
        6.5.9 Benelux Nuclear Medicine/Radiopharmaceutic Market Size, 2017-2028
    6.6 Asia
        6.6.1 By Region - Asia Nuclear Medicine/Radiopharmaceutic Revenue, 2017-2028
        6.6.2 By Region - Asia Nuclear Medicine/Radiopharmaceutic Sales, 2017-2028
        6.6.3 China Nuclear Medicine/Radiopharmaceutic Market Size, 2017-2028
        6.6.4 Japan Nuclear Medicine/Radiopharmaceutic Market Size, 2017-2028
        6.6.5 South Korea Nuclear Medicine/Radiopharmaceutic Market Size, 2017-2028
        6.6.6 Southeast Asia Nuclear Medicine/Radiopharmaceutic Market Size, 2017-2028
        6.6.7 India Nuclear Medicine/Radiopharmaceutic Market Size, 2017-2028
    6.7 South America
        6.7.1 By Country - South America Nuclear Medicine/Radiopharmaceutic Revenue, 2017-2028
        6.7.2 By Country - South America Nuclear Medicine/Radiopharmaceutic Sales, 2017-2028
        6.7.3 Brazil Nuclear Medicine/Radiopharmaceutic Market Size, 2017-2028
        6.7.4 Argentina Nuclear Medicine/Radiopharmaceutic Market Size, 2017-2028
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Nuclear Medicine/Radiopharmaceutic Revenue, 2017-2028
        6.8.2 By Country - Middle East & Africa Nuclear Medicine/Radiopharmaceutic Sales, 2017-2028
        6.8.3 Turkey Nuclear Medicine/Radiopharmaceutic Market Size, 2017-2028
        6.8.4 Israel Nuclear Medicine/Radiopharmaceutic Market Size, 2017-2028
        6.8.5 Saudi Arabia Nuclear Medicine/Radiopharmaceutic Market Size, 2017-2028
        6.8.6 UAE Nuclear Medicine/Radiopharmaceutic Market Size, 2017-2028
7 Manufacturers & Brands Profiles
    7.1 GE Healthcare
        7.1.1 GE Healthcare Corporate Summary
        7.1.2 GE Healthcare Business Overview
        7.1.3 GE Healthcare Nuclear Medicine/Radiopharmaceutic Major Product Offerings
        7.1.4 GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales and Revenue in Global (2017-2022)
        7.1.5 GE Healthcare Key News
    7.2 Bracco Imaging
        7.2.1 Bracco Imaging Corporate Summary
        7.2.2 Bracco Imaging Business Overview
        7.2.3 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Major Product Offerings
        7.2.4 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Sales and Revenue in Global (2017-2022)
        7.2.5 Bracco Imaging Key News
    7.3 Mallinckrodt
        7.3.1 Mallinckrodt Corporate Summary
        7.3.2 Mallinckrodt Business Overview
        7.3.3 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Major Product Offerings
        7.3.4 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales and Revenue in Global (2017-2022)
        7.3.5 Mallinckrodt Key News
    7.4 Lantheus Medical Imaging
        7.4.1 Lantheus Medical Imaging Corporate Summary
        7.4.2 Lantheus Medical Imaging Business Overview
        7.4.3 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Major Product Offerings
        7.4.4 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales and Revenue in Global (2017-2022)
        7.4.5 Lantheus Medical Imaging Key News
    7.5 Bayer
        7.5.1 Bayer Corporate Summary
        7.5.2 Bayer Business Overview
        7.5.3 Bayer Nuclear Medicine/Radiopharmaceutic Major Product Offerings
        7.5.4 Bayer Nuclear Medicine/Radiopharmaceutic Sales and Revenue in Global (2017-2022)
        7.5.5 Bayer Key News
    7.6 Jubilant Pharma
        7.6.1 Jubilant Pharma Corporate Summary
        7.6.2 Jubilant Pharma Business Overview
        7.6.3 Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Major Product Offerings
        7.6.4 Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Sales and Revenue in Global (2017-2022)
        7.6.5 Jubilant Pharma Key News
    7.7 Nordion
        7.7.1 Nordion Corporate Summary
        7.7.2 Nordion Business Overview
        7.7.3 Nordion Nuclear Medicine/Radiopharmaceutic Major Product Offerings
        7.7.4 Nordion Nuclear Medicine/Radiopharmaceutic Sales and Revenue in Global (2017-2022)
        7.7.5 Nordion Key News
    7.8 Eli Lilly
        7.8.1 Eli Lilly Corporate Summary
        7.8.2 Eli Lilly Business Overview
        7.8.3 Eli Lilly Nuclear Medicine/Radiopharmaceutic Major Product Offerings
        7.8.4 Eli Lilly Nuclear Medicine/Radiopharmaceutic Sales and Revenue in Global (2017-2022)
        7.8.5 Eli Lilly Key News
    7.9 SIEMENS
        7.9.1 SIEMENS Corporate Summary
        7.9.2 SIEMENS Business Overview
        7.9.3 SIEMENS Nuclear Medicine/Radiopharmaceutic Major Product Offerings
        7.9.4 SIEMENS Nuclear Medicine/Radiopharmaceutic Sales and Revenue in Global (2017-2022)
        7.9.5 SIEMENS Key News
    7.10 China Isotope & Radiation
        7.10.1 China Isotope & Radiation Corporate Summary
        7.10.2 China Isotope & Radiation Business Overview
        7.10.3 China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Major Product Offerings
        7.10.4 China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Sales and Revenue in Global (2017-2022)
        7.10.5 China Isotope & Radiation Key News
    7.11 Yantai Dongcheng Biochemicals
        7.11.1 Yantai Dongcheng Biochemicals Corporate Summary
        7.11.2 Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Business Overview
        7.11.3 Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Major Product Offerings
        7.11.4 Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Sales and Revenue in Global (2017-2022)
        7.11.5 Yantai Dongcheng Biochemicals Key News
8 Global Nuclear Medicine/Radiopharmaceutic Production Capacity, Analysis
    8.1 Global Nuclear Medicine/Radiopharmaceutic Production Capacity, 2017-2028
    8.2 Nuclear Medicine/Radiopharmaceutic Production Capacity of Key Manufacturers in Global Market
    8.3 Global Nuclear Medicine/Radiopharmaceutic Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Nuclear Medicine/Radiopharmaceutic Supply Chain Analysis
    10.1 Nuclear Medicine/Radiopharmaceutic Industry Value Chain
    10.2 Nuclear Medicine/Radiopharmaceutic Upstream Market
    10.3 Nuclear Medicine/Radiopharmaceutic Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Nuclear Medicine/Radiopharmaceutic Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

List of Tables
    Table 1. Key Players of Nuclear Medicine/Radiopharmaceutic in Global Market
    Table 2. Top Nuclear Medicine/Radiopharmaceutic Players in Global Market, Ranking by Revenue (2021)
    Table 3. Global Nuclear Medicine/Radiopharmaceutic Revenue by Companies, (US$, Mn), 2017-2022
    Table 4. Global Nuclear Medicine/Radiopharmaceutic Revenue Share by Companies, 2017-2022
    Table 5. Global Nuclear Medicine/Radiopharmaceutic Sales by Companies, (Kiloton), 2017-2022
    Table 6. Global Nuclear Medicine/Radiopharmaceutic Sales Share by Companies, 2017-2022
    Table 7. Key Manufacturers Nuclear Medicine/Radiopharmaceutic Price (2017-2022) & (US$/Ton)
    Table 8. Global Manufacturers Nuclear Medicine/Radiopharmaceutic Product Type
    Table 9. List of Global Tier 1 Nuclear Medicine/Radiopharmaceutic Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Nuclear Medicine/Radiopharmaceutic Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type ? Global Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Global Nuclear Medicine/Radiopharmaceutic Revenue (US$, Mn), 2017-2022
    Table 13. By Type - Global Nuclear Medicine/Radiopharmaceutic Revenue (US$, Mn), 2023-2028
    Table 14. By Type - Global Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), 2017-2022
    Table 15. By Type - Global Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), 2023-2028
    Table 16. By Application ? Global Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2021 & 2028
    Table 17. By Application - Global Nuclear Medicine/Radiopharmaceutic Revenue (US$, Mn), 2017-2022
    Table 18. By Application - Global Nuclear Medicine/Radiopharmaceutic Revenue (US$, Mn), 2023-2028
    Table 19. By Application - Global Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), 2017-2022
    Table 20. By Application - Global Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), 2023-2028
    Table 21. By Region ? Global Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2021 VS 2028
    Table 22. By Region - Global Nuclear Medicine/Radiopharmaceutic Revenue (US$, Mn), 2017-2022
    Table 23. By Region - Global Nuclear Medicine/Radiopharmaceutic Revenue (US$, Mn), 2023-2028
    Table 24. By Region - Global Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), 2017-2022
    Table 25. By Region - Global Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), 2023-2028
    Table 26. By Country - North America Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - North America Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - North America Nuclear Medicine/Radiopharmaceutic Sales, (Kiloton), 2017-2022
    Table 29. By Country - North America Nuclear Medicine/Radiopharmaceutic Sales, (Kiloton), 2023-2028
    Table 30. By Country - Europe Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2022
    Table 31. By Country - Europe Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2023-2028
    Table 32. By Country - Europe Nuclear Medicine/Radiopharmaceutic Sales, (Kiloton), 2017-2022
    Table 33. By Country - Europe Nuclear Medicine/Radiopharmaceutic Sales, (Kiloton), 2023-2028
    Table 34. By Region - Asia Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2022
    Table 35. By Region - Asia Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2023-2028
    Table 36. By Region - Asia Nuclear Medicine/Radiopharmaceutic Sales, (Kiloton), 2017-2022
    Table 37. By Region - Asia Nuclear Medicine/Radiopharmaceutic Sales, (Kiloton), 2023-2028
    Table 38. By Country - South America Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2022
    Table 39. By Country - South America Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2023-2028
    Table 40. By Country - South America Nuclear Medicine/Radiopharmaceutic Sales, (Kiloton), 2017-2022
    Table 41. By Country - South America Nuclear Medicine/Radiopharmaceutic Sales, (Kiloton), 2023-2028
    Table 42. By Country - Middle East & Africa Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2022
    Table 43. By Country - Middle East & Africa Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2023-2028
    Table 44. By Country - Middle East & Africa Nuclear Medicine/Radiopharmaceutic Sales, (Kiloton), 2017-2022
    Table 45. By Country - Middle East & Africa Nuclear Medicine/Radiopharmaceutic Sales, (Kiloton), 2023-2028
    Table 46. GE Healthcare Corporate Summary
    Table 47. GE Healthcare Nuclear Medicine/Radiopharmaceutic Product Offerings
    Table 48. GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
    Table 49. Bracco Imaging Corporate Summary
    Table 50. Bracco Imaging Nuclear Medicine/Radiopharmaceutic Product Offerings
    Table 51. Bracco Imaging Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
    Table 52. Mallinckrodt Corporate Summary
    Table 53. Mallinckrodt Nuclear Medicine/Radiopharmaceutic Product Offerings
    Table 54. Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
    Table 55. Lantheus Medical Imaging Corporate Summary
    Table 56. Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Product Offerings
    Table 57. Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
    Table 58. Bayer Corporate Summary
    Table 59. Bayer Nuclear Medicine/Radiopharmaceutic Product Offerings
    Table 60. Bayer Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
    Table 61. Jubilant Pharma Corporate Summary
    Table 62. Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Product Offerings
    Table 63. Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
    Table 64. Nordion Corporate Summary
    Table 65. Nordion Nuclear Medicine/Radiopharmaceutic Product Offerings
    Table 66. Nordion Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
    Table 67. Eli Lilly Corporate Summary
    Table 68. Eli Lilly Nuclear Medicine/Radiopharmaceutic Product Offerings
    Table 69. Eli Lilly Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
    Table 70. SIEMENS Corporate Summary
    Table 71. SIEMENS Nuclear Medicine/Radiopharmaceutic Product Offerings
    Table 72. SIEMENS Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
    Table 73. China Isotope & Radiation Corporate Summary
    Table 74. China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Product Offerings
    Table 75. China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
    Table 76. Yantai Dongcheng Biochemicals Corporate Summary
    Table 77. Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Product Offerings
    Table 78. Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
    Table 79. Nuclear Medicine/Radiopharmaceutic Production Capacity (Kiloton) of Key Manufacturers in Global Market, 2020-2022 (Kiloton)
    Table 80. Global Nuclear Medicine/Radiopharmaceutic Capacity Market Share of Key Manufacturers, 2020-2022
    Table 81. Global Nuclear Medicine/Radiopharmaceutic Production by Region, 2017-2022 (Kiloton)
    Table 82. Global Nuclear Medicine/Radiopharmaceutic Production by Region, 2023-2028 (Kiloton)
    Table 83. Nuclear Medicine/Radiopharmaceutic Market Opportunities & Trends in Global Market
    Table 84. Nuclear Medicine/Radiopharmaceutic Market Drivers in Global Market
    Table 85. Nuclear Medicine/Radiopharmaceutic Market Restraints in Global Market
    Table 86. Nuclear Medicine/Radiopharmaceutic Raw Materials
    Table 87. Nuclear Medicine/Radiopharmaceutic Raw Materials Suppliers in Global Market
    Table 88. Typical Nuclear Medicine/Radiopharmaceutic Downstream
    Table 89. Nuclear Medicine/Radiopharmaceutic Downstream Clients in Global Market
    Table 90. Nuclear Medicine/Radiopharmaceutic Distributors and Sales Agents in Global Market
List of Figures
    Figure 1. Nuclear Medicine/Radiopharmaceutic Segment by Type
    Figure 2. Nuclear Medicine/Radiopharmaceutic Segment by Application
    Figure 3. Global Nuclear Medicine/Radiopharmaceutic Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Nuclear Medicine/Radiopharmaceutic Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Nuclear Medicine/Radiopharmaceutic Revenue, 2017-2028 (US$, Mn)
    Figure 7. Nuclear Medicine/Radiopharmaceutic Sales in Global Market: 2017-2028 (Kiloton)
    Figure 8. The Top 3 and 5 Players Market Share by Nuclear Medicine/Radiopharmaceutic Revenue in 2021
    Figure 9. By Type - Global Nuclear Medicine/Radiopharmaceutic Sales Market Share, 2017-2028
    Figure 10. By Type - Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share, 2017-2028
    Figure 11. By Type - Global Nuclear Medicine/Radiopharmaceutic Price (US$/Ton), 2017-2028
    Figure 12. By Application - Global Nuclear Medicine/Radiopharmaceutic Sales Market Share, 2017-2028
    Figure 13. By Application - Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share, 2017-2028
    Figure 14. By Application - Global Nuclear Medicine/Radiopharmaceutic Price (US$/Ton), 2017-2028
    Figure 15. By Region - Global Nuclear Medicine/Radiopharmaceutic Sales Market Share, 2017-2028
    Figure 16. By Region - Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share, 2017-2028
    Figure 17. By Country - North America Nuclear Medicine/Radiopharmaceutic Revenue Market Share, 2017-2028
    Figure 18. By Country - North America Nuclear Medicine/Radiopharmaceutic Sales Market Share, 2017-2028
    Figure 19. US Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2028
    Figure 20. Canada Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2028
    Figure 21. Mexico Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2028
    Figure 22. By Country - Europe Nuclear Medicine/Radiopharmaceutic Revenue Market Share, 2017-2028
    Figure 23. By Country - Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share, 2017-2028
    Figure 24. Germany Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2028
    Figure 25. France Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2028
    Figure 26. U.K. Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2028
    Figure 27. Italy Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2028
    Figure 28. Russia Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2028
    Figure 29. Nordic Countries Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2028
    Figure 30. Benelux Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2028
    Figure 31. By Region - Asia Nuclear Medicine/Radiopharmaceutic Revenue Market Share, 2017-2028
    Figure 32. By Region - Asia Nuclear Medicine/Radiopharmaceutic Sales Market Share, 2017-2028
    Figure 33. China Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2028
    Figure 34. Japan Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2028
    Figure 35. South Korea Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2028
    Figure 36. Southeast Asia Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2028
    Figure 37. India Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2028
    Figure 38. By Country - South America Nuclear Medicine/Radiopharmaceutic Revenue Market Share, 2017-2028
    Figure 39. By Country - South America Nuclear Medicine/Radiopharmaceutic Sales Market Share, 2017-2028
    Figure 40. Brazil Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2028
    Figure 41. Argentina Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2028
    Figure 42. By Country - Middle East & Africa Nuclear Medicine/Radiopharmaceutic Revenue Market Share, 2017-2028
    Figure 43. By Country - Middle East & Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share, 2017-2028
    Figure 44. Turkey Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2028
    Figure 45. Israel Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2028
    Figure 46. Saudi Arabia Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2028
    Figure 47. UAE Nuclear Medicine/Radiopharmaceutic Revenue, (US$, Mn), 2017-2028
    Figure 48. Global Nuclear Medicine/Radiopharmaceutic Production Capacity (Kiloton), 2017-2028
    Figure 49. The Percentage of Production Nuclear Medicine/Radiopharmaceutic by Region, 2021 VS 2028
    Figure 50. Nuclear Medicine/Radiopharmaceutic Industry Value Chain
    Figure 51. Marketing Channels

This report contains market size and forecasts of Nuclear Medicine/Radiopharmaceutic in global, including the following market information:
Global Nuclear Medicine/Radiopharmaceutic Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Nuclear Medicine/Radiopharmaceutic Market Sales, 2017-2022, 2023-2028, (Kiloton)
Global top five Nuclear Medicine/Radiopharmaceutic companies in 2021 (%)
The global Nuclear Medicine/Radiopharmaceutic market was valued at 5062.8 million in 2021 and is projected to reach US$ 8421.9 million by 2028, at a CAGR of 7.5% during the forecast period.
The U.S. Market is Estimated at $  Million in 2021, While China is Forecast to Reach $  Million by 2028.
Tc-99 Segment to Reach $  Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Nuclear Medicine/Radiopharmaceutic include GE Healthcare, Bracco Imaging, Mallinckrodt, Lantheus Medical Imaging, Bayer, Jubilant Pharma, Nordion, Eli Lilly and SIEMENS, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Nuclear Medicine/Radiopharmaceutic manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nuclear Medicine/Radiopharmaceutic Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Nuclear Medicine/Radiopharmaceutic Market Segment Percentages, by Type, 2021 (%)
    Tc-99
    I-123/131
    In-111
    Xe-133
    Th-201
    Ga-67
    Other
Global Nuclear Medicine/Radiopharmaceutic Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Nuclear Medicine/Radiopharmaceutic Market Segment Percentages, by Application, 2021 (%)
    Diagnostic
    Therapeutic
Global Nuclear Medicine/Radiopharmaceutic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Nuclear Medicine/Radiopharmaceutic Market Segment Percentages, By Region and Country, 2021 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nuclear Medicine/Radiopharmaceutic revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Nuclear Medicine/Radiopharmaceutic revenues share in global market, 2021 (%)
Key companies Nuclear Medicine/Radiopharmaceutic sales in global market, 2017-2022 (Estimated), (Kiloton)
Key companies Nuclear Medicine/Radiopharmaceutic sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
    GE Healthcare
    Bracco Imaging
    Mallinckrodt
    Lantheus Medical Imaging
    Bayer
    Jubilant Pharma
    Nordion
    Eli Lilly
    SIEMENS
    China Isotope & Radiation
    Yantai Dongcheng Biochemicals